These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2164207)

  • 1. [Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer].
    Guzman J; Kraft A; Bross KJ; Würtemberger G; Costabel U
    Pneumologie; 1990 Feb; 44 Suppl 1():601-2. PubMed ID: 2164207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural effusions due to small cell carcinoma of the lung. An immunocytochemical cell-surface analysis of lymphocytes and tumor cells.
    Guzman J; Bross KJ; Costabel U
    Acta Cytol; 1990; 34(4):497-501. PubMed ID: 2165344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
    Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Mikroulis D; Didilis V; Bitzikas N; Bougioukas G
    Minerva Med; 2002 Dec; 93(6):479-83. PubMed ID: 12515971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins.
    Abramenko IV; Gluzman DF; Sklyarenko LM; Pisnyachevskaya GV; Pinchouk VG
    Anticancer Res; 1991; 11(2):629-34. PubMed ID: 1712178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytodiagnosis and marker determination in pleural effusion].
    Odermatt BF; Pedio G
    Schweiz Med Wochenschr; 1986 Dec; 116(49):1709-16. PubMed ID: 3544207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
    Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
    Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
    Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
    Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
    Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
    Vignale L; Galli G; Rossi PC; Parentini GC
    Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique cytologic picture of oat cell carcinoma in effusions.
    Salhadin A; Nasiell M; Nasiell K; Silfverswärd C; Hjerpe A; Wadäs AM; Enstad I
    Acta Cytol; 1976; 20(4):298-302. PubMed ID: 183433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.